Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

The Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators

    Research output: Contribution to journalArticlepeer-review

    881 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)1174-1183
    Number of pages10
    JournalThe Lancet
    Volume372
    Issue number9644
    DOIs
    Publication statusPublished (VoR) - 27 Sept 2008

    Fingerprint

    Dive into the research topics of 'Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial'. Together they form a unique fingerprint.

    Cite this